Discounted Cash Flow (DCF) Analysis Levered
Reviv3 Procare Company (RVIV)
$0.38
+0.01 (+2.70%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.93 | 0.99 | 1.01 | 1.63 | 2.34 | 2.99 | 3.84 | 4.92 | 6.31 | 8.08 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -0.47 | -0.18 | -0.09 | 0.05 | -0.13 | -0.47 | -0.61 | -0.78 | -1 | -1.28 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 | -0.05 | -0.06 | -0.08 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -0.47 | -0.19 | -0.10 | 0.03 | -0.15 | -0.50 | -0.64 | -0.82 | -1.06 | -1.35 |
Weighted Average Cost Of Capital
| Share price | $ 0.38 |
|---|---|
| Beta | -1.127 |
| Diluted Shares Outstanding | 41.95 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 3.13% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | -1.824 |
| Total Debt | 0.21 |
| Total Equity | 15.94 |
| Total Capital | 16.15 |
| Debt Weighting | 1.29 |
| Equity Weighting | 98.71 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 0.93 | 0.99 | 1.01 | 1.63 | 2.34 | 2.99 | 3.84 | 4.92 | 6.31 | 8.08 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -0.47 | -0.18 | -0.09 | 0.05 | -0.13 | -0.47 | -0.61 | -0.78 | -1 | -1.28 |
| Capital Expenditure | -0 | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.04 | -0.05 | -0.06 | -0.08 |
| Free Cash Flow | -0.47 | -0.19 | -0.10 | 0.03 | -0.15 | -0.50 | -0.64 | -0.82 | -1.06 | -1.35 |
| WACC | ||||||||||
| PV LFCF | -0.51 | -0.67 | -0.87 | -1.13 | -1.48 | |||||
| SUM PV LFCF | -4.66 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | -1.76 |
| Free cash flow (t + 1) | -1.38 |
| Terminal Value | 36.75 |
| Present Value of Terminal Value | 40.17 |
Intrinsic Value
| Enterprise Value | 35.50 |
|---|---|
| Net Debt | -0.16 |
| Equity Value | 35.67 |
| Shares Outstanding | 41.95 |
| Equity Value Per Share | 0.85 |